NCT02799407 (ECONSENT) is a NA clinical trial of ResearchKit Consent in Informed Consent, sponsored by Duke University.

Who is sponsoring NCT02799407?

NCT02799407 is sponsored by Duke University.

What drugs are being tested in NCT02799407?

Interventions in NCT02799407: ResearchKit Consent.

What condition does NCT02799407 study?

NCT02799407 studies Informed Consent.

Is NCT02799407 still recruiting?

NCT02799407 is currently withdrawn. Last updated 12 April 2024.

Last reviewed 2024-04-12 · How we verify

NCT02799407: ECONSENT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Electronic Consent of Numerous Subjects Employing Novel Techniques Trial

Withdrawn NA Last updated 12 April 2024

What this trial tests

NA trial testing ResearchKit Consent in Informed Consent. Withdrawn.

Timeline

1 November 2018

Primary endpoint
1 August 2019

1 August 2019

Quick facts

Lead sponsor	Duke University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Start date	1 November 2018
Primary completion	1 August 2019
Estimated completion	1 August 2019

Drugs / interventions tested

ResearchKit Consent

Conditions studied

Informed Consent — all drugs for Informed Consent →

Sponsor

Duke University

Who can join

18 and older, any sex, with Informed Consent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the modular, multi-tiered consent process featured in Apple's ResearchKit (RK) to the standard consent process. The primary objective is to determine whether participants using the ResearchKit consent form have a significantly higher comprehension of the elements of consent than participants using the standard consent form.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Informed Consent

Currently open trials in the same condition.

NCT07303517 — AI-Driven Consent Simplification Study · recruiting
NCT06192511 — Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening · NA · recruiting
NCT07074925 — Video-Assisted Informed Consent for Neonatal Lumbar Puncture · NA · active not recruiting

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02799407 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 12 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02799407.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing